296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 260 institutions

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Posters by Title

Showing 296 results.

P156

Earlier Treatment Yields Better Outcomes: 5 Years of Pegcetacoplan Treatment For Geographic Atrophy Secondary to AMD

Richard Gale, Dilsher S Dhoot, Maximilian Pfau, Sunir Garg, David Lally, Allen Hu, Andrew Chang, Laurentino Biccas, Nicole Eter, Jennifer Arnold, Chao Li, Felix Yemanyi, Michael Friedman, Ca...

Hull York Medical School, University of York, Heslington, UK, California Retina Consultants/Retina Consultants of America, Santa Barbara, CA, USA, University of Bonn, Bonn, Germany, MidAtlantic Retina, The Reti...

Poster Presenter: Richard Gale

P040

Early experiences of the Yokoyama Loop Myopexy in the United Kingdom

Katherine Rennie, Selina Tomlinson

Royal United Hospital, Bath

Poster Presenter: Katherine Rennie

Audio

RCOphth Annual Congress 2026

Posters by Title

Earlier Treatment Yields Better Outcomes: 5 Years of Pegcetacoplan Treatment For Geographic Atrophy Secondary to AMD

Early experiences of the Yokoyama Loop Myopexy in the United Kingdom

Early Real-World Outcomes of Faricimab versus Aflibercept 8mg in Treatment Na?ve Neovascular Age Related Macular Degeneration�

Early�Real-World�Effectiveness and�Safety of�Faricimab in�Eyes�With�Retinal�Vein�Occlusion (RVO):�3-Month�Results�From�the UK FARWIDE-RVO�Study

Effect of Aflibercept 2mg and Faricimab 6mg on the height of Retinal Pigment Epithelial Detachment in Neovascular AMD during the loading dose phase .

Effectiveness of Prism Therapy versus Botulinum Toxin Injection in the Management of Sixth Cranial Nerve Palsy: A Systematic Review and Meta-Analysis

Efficacy and Safety of implantable phakic contact lens versus implantable collamer lens in myopia correction: A Systematic Review and Meta-analysis

Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: Week 16 Results from the Phase 3 MEERKAT/SANDCAT Trials

Efficacy of Faricimab versus Aflibercept-8mg in patients with treatment na?ve diabetic macular oedema. Real World Outcomes.